Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude El Kouri

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|November 9, 2016
[Lobular breast cancer metastasis to the colon]Alain Lortholary, Benoît Humeau, Hélène Castanié, et al.
Presse Medicale (Paris, France : 1983)|May 25, 2007
[Paclitaxel-induced lupus]Alain Lortholary, Myriam Cary-Ten Have Dallinga, Claude El Kouri, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2013
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patientsAudrey Vallée, Marie Marcq, Acya Bizieux, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2013
Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfactionThierry Lebret, Jean-Loup Mouysset, Alain Lortholary, et al.
Bulletin Du Cancer|March 23, 2013
[Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction]Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, et al.
European Journal of Dermatology : EJD|August 23, 2013
Atypical cutaneous vasculitis under lapatinibLucie Peuvrel, Gaëlle Quereux, Anabelle Brocard, et al.
Lung Cancer (Amsterdam, Netherlands)|February 26, 2013
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trialRadj Gervais, Gilles Robinet, Christelle Clément-Duchêne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO studyThomas Bachelot, Céline Bourgier, Claire Cropet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III studyCesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Clinical Genitourinary Cancer|October 11, 2021
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate CancerMarc Pujalte Martin, Delphine Borchiellini, Brice Thamphya, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|November 9, 2016
[Lobular breast cancer metastasis to the colon]Alain Lortholary, Benoît Humeau, Hélène Castanié, et al.
Presse Medicale (Paris, France : 1983)|May 25, 2007
[Paclitaxel-induced lupus]Alain Lortholary, Myriam Cary-Ten Have Dallinga, Claude El Kouri, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2013
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patientsAudrey Vallée, Marie Marcq, Acya Bizieux, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2013
Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfactionThierry Lebret, Jean-Loup Mouysset, Alain Lortholary, et al.
Bulletin Du Cancer|March 23, 2013
[Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction]Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, et al.
European Journal of Dermatology : EJD|August 23, 2013
Atypical cutaneous vasculitis under lapatinibLucie Peuvrel, Gaëlle Quereux, Anabelle Brocard, et al.
Lung Cancer (Amsterdam, Netherlands)|February 26, 2013
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trialRadj Gervais, Gilles Robinet, Christelle Clément-Duchêne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO studyThomas Bachelot, Céline Bourgier, Claire Cropet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III studyCesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Clinical Genitourinary Cancer|October 11, 2021
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate CancerMarc Pujalte Martin, Delphine Borchiellini, Brice Thamphya, et al.
Pageof 2